Cargando…

Mutational spectrum of WTX, WT1, CTNNB1, APC and PLCG2 genes in Wilms tumor defined by massive parallel resequencing

Detalles Bibliográficos
Autores principales:	Barros, Bruna D, Torrezan, Giovana T, Ferreira, Elisa N, Maschietto, Mariana, Krepíschi, Ana CV, Carraro, Dirce M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467462/ http://dx.doi.org/10.1186/1753-6561-6-S6-P52

Ejemplares similares

A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype
por: Torrezan, Giovana Tardin, et al.
Publicado: (2012)

Mutational spectrum of the APC and MUTYH genes and genotype–phenotype correlations in Brazilian FAP, AFAP, and MAP patients
por: Torrezan, Giovana Tardin, et al.
Publicado: (2013)

Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: Case report
por: Torrezan, Giovana T, et al.
Publicado: (2011)

Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
por: Torrezan, Giovana T., et al.
Publicado: (2014)

Association of Folate and Vitamins Involved in the 1-Carbon Cycle with Polymorphisms in the Methylenetetrahydrofolate Reductase Gene (MTHFR) and Global DNA Methylation in Patients with Colorectal Cancer
por: Ferrari, Ariana, et al.
Publicado: (2019)

CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
por: da Silva, Roseli, et al.
Publicado: (2013)

The Wilms’ tumor (WT1) gene: Methods and protocols
por: Agrawal, Suraksha
Publicado: (2018)

Wilms Tumor Gene on X Chromosome (WTX) Inhibits Degradation of NRF2 Protein through Competitive Binding to KEAP1 Protein
por: Camp, Nathan D., et al.
Publicado: (2012)

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
por: Krepischi, A. C. V., et al.
Publicado: (2016)

Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011)

Wilms Tumor-1 (WT1) rs16754 Polymorphism
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant
por: Riechelmann, Rachel P, et al.
Publicado: (2022)

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
por: Wagner, Nicole, et al.
Publicado: (2021)

Pitfalls in genetic testing: a case of a SNP in primer‐annealing region leading to allele dropout in BRCA1
por: Silva, Felipe Carneiro, et al.
Publicado: (2017)

Structures of the APC–ARM domain in complexes with discrete Amer1/WTX fragments reveal that it uses a consensus mode to recognize its binding partners
por: Zhang, Zhenyi, et al.
Publicado: (2015)

The WTX/AMER1 gene family: evolution, signature and function
por: Boutet, Agnès, et al.
Publicado: (2010)

Recurrent PTPRB and PLCG1 mutations in angiosarcoma
por: Behjati, Sam, et al.
Publicado: (2014)

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
por: Silva, Felipe C, et al.
Publicado: (2014)

Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors
por: Royer‐Pokora, Brigitte, et al.
Publicado: (2018)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
por: Wagner, Nicole, et al.
Publicado: (2021)

TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
por: Makki, Mohammad Shahidul, et al.
Publicado: (2008)

Nephron, Wilms’ tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice
por: Kato, Takashi, et al.
Publicado: (2017)

Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia
por: Maschietto, Mariana, et al.
Publicado: (2015)

Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door
por: Donadio, Mauro Daniel Spina, et al.
Publicado: (2022)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo
por: Benteyn, Daphné, et al.
Publicado: (2013)

Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families
por: Fidalgo, Felipe, et al.
Publicado: (2022)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
por: Lim, Che Kang, et al.
Publicado: (2007)

The Wilms tumor protein Wt1 contributes to female fertility by regulating oviductal proteostasis
por: Nathan, Abinaya, et al.
Publicado: (2017)

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
por: Karachaliou, Georgia Sofia, et al.
Publicado: (2022)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
por: Busse, Antonia, et al.
Publicado: (2010)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations
por: Royer-Pokora, Brigitte, et al.
Publicado: (2020)

TERT Expression in Wilms Tumor Is Regulated by Promoter Mutation or Hypermethylation, WT1, and N-MYC
por: Jablonowski, Carolyn M., et al.
Publicado: (2022)

Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant
por: Falcone, Maria Pia, et al.
Publicado: (2021)

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2
por: Rapley, E A, et al.
Publicado: (2000)

Wilms’ tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis
por: Lu, Jingjing, et al.
Publicado: (2018)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019)

Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes
por: Shiseki, Masayuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddm4s1m26srvbjra126j0ims9i